US 12,122,848 B2
Compositions and methods for treating fibroids
Omid Khorram, Rolling Hills, CA (US); and Tsai-Der Chuang, Inglewood, CA (US)
Assigned to THE LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER, Torrance, CA (US)
Filed by THE LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER, Torrance, CA (US)
Filed on Jul. 1, 2021, as Appl. No. 17/365,723.
Claims priority of provisional application 63/050,034, filed on Jul. 9, 2020.
Prior Publication US 2022/0010028 A1, Jan. 13, 2022
Int. Cl. C07K 16/40 (2006.01); A61K 31/4188 (2006.01); A61K 31/4245 (2006.01); A61K 31/4439 (2006.01); A61K 31/47 (2006.01); A61K 31/7105 (2006.01); A61P 15/00 (2006.01); A61P 19/04 (2006.01)
CPC C07K 16/40 (2013.01) [A61K 31/4188 (2013.01); A61K 31/4245 (2013.01); A61K 31/4439 (2013.01); A61K 31/47 (2013.01); A61K 31/7105 (2013.01); A61P 15/00 (2018.01); A61P 19/04 (2018.01)] 7 Claims
 
1. A method of treating fibroid in a patient in need thereof, comprising administering to the patient a therapeutically effective amount of 680C91.